Copper Chaperone for Cu/Zn Superoxide Dismutase is a sensitive biomarker of mild copper deficiency induced by moderately high intakes of zinc
© Iskandar et al; licensee BioMed Central Ltd. 2005
Received: 23 September 2005
Accepted: 24 November 2005
Published: 24 November 2005
Small increases in zinc (Zn) consumption above recommended amounts have been shown to reduce copper (Cu) status in experimental animals and humans. Recently, we have reported that copper chaperone for Cu/Zn superoxide dismutase (CCS) protein level is increased in tissues of overtly Cu-deficient rats and proposed CCS as a novel biomarker of Cu status.
Weanling male Wistar rats were fed one of four diets normal in Cu and containing normal (30 mg Zn/kg diet) or moderately high (60, 120 or 240 mg Zn/kg diet) amounts of Zn for 5 weeks. To begin to examine the clinical relevance of CCS, we compared the sensitivity of CCS to mild Cu deficiency, induced by moderately high intakes of Zn, with conventional indices of Cu status.
Liver and erythrocyte CCS expression was significantly (P < 0.05) increased in rats fed the Zn-60 and/or Zn-120 diet compared to rats fed normal levels of Zn (Zn-30). Erythrocyte CCS expression was the most sensitive measure of reduced Cu status and was able to detect a decrease in Cu nutriture in rats fed only twice the recommended amount of Zn. Liver, erythrocyte and white blood cell CCS expression showed a significant (P < 0.05) inverse correlation with plasma and liver Cu concentrations and caeruloplasmin activity. Unexpectedly, rats fed the highest level of Zn (Zn-240) showed overall better Cu status than rats fed a lower level of elevated Zn (Zn-120). Improved Cu status in these rats correlated with increased duodenal mRNA expression of several Zn-trafficking proteins (i.e. MT-1, ZnT-1, ZnT-2 and ZnT-4).
Collectively, these data show that CCS is a sensitive measure of Zn-induced mild Cu deficiency and demonstrate a dose-dependent biphasic response for reduced Cu status by moderately high intakes of Zn.
Zinc (Zn) and copper (Cu) play vital roles as structural and catalytic components of metalloenzymes and are essential nutrients required for growth and development [1–3]. It is well recognized that consuming large quantities of Zn for extended periods of time causes severe Cu deficiency and can lead to the development of anaemia and other abnormalities [4–8]. Of potentially greater significance, however, are studies showing that even small increases in Zn consumption above recommended amounts depress Cu status in experimental animals [9, 10] and humans [11, 12]. This strong antagonism of excess Zn to Cu status was the basis for setting the Tolerable Upper Intake Levels (ULs) for Zn . At present, the mechanism by which Zn impedes Cu absorption is not known.
In humans, overt Cu deficiency is uncommon and usually only seen in specific situations . However, mild Cu deficiency from consuming diets inadequate in Cu [14, 15] or high in Zn  may be of concern. Notably, studies have shown that a large proportion of young children have Zn intakes exceeding the ULs and much of the Zn consumed by these children is from Zn-fortified foods [16–18]. Although overt Zn toxicity has not been reported in these children, excessive Zn intake may cause small but potentially harmful reductions in Cu balance, stressing the need for sensitive biomarkers able to detect mild Cu deficiency.
Insertion of Cu into Cu/Zn superoxide dismutase (SOD1) requires the copper chaperone for SOD1 (CCS). We have previously shown that CCS protein is up-regulated in liver and erythrocytes of Cu-deficient rats  and Cu regulates the degradation of CCS by the 26 S proteosome . Another group has since reported a similar increase in CCS in tissues of Cu-deficient rats and mice [21, 22]. CCS is a promising biomarker of reduced Cu status, as CCS protein level is more responsive to Cu deficiency than reduction in SOD1 activity , the endpoint used to set the ULs for Zn . Further, CCS is particularly appealing given that commonly used measures of Cu status are affected by various common conditions unrelated to Cu nutriture [14, 15, 23–25] and thought to be insensitive to marginal deficiency [14, 15, 26]. The latter is underscored by experiments in rats showing that diets marginally low in Cu induce abnormalities in heart morphology and function, but minimal changes in conventional indices of Cu status [27, 28].
Several reports have established increased CCS protein in tissues of overtly Cu-deficient rats and mice [19–22], however, it is not known whether CCS is responsive to small reductions in Cu status. The objectives of this study were two-fold; (1) to examine the effects of graded levels of moderately high dietary Zn on Cu status and (2) to evaluate the ability of CCS to detect small reductions in Cu nutriture, induced by excess Zn, as a first step in determining the usefulness of CCS as a biomarker that can be used in a clinical setting.
Animals and Test Diets
Weanling (21-day-old) male Wistar rats (n = 12/diet group) (Charles River Canada, St. Constant, Canada) had free access to one of 5 test diets  and demineralised drinking water. Food consumption and body weight were measured weekly. After 5 weeks of consuming the diets, rats were killed by exsanguination while anesthetised with 3% isoflurane. Blood was withdrawn from the abdominal aorta. The intestine was extracted and intestinal contents removed by washing with isotonic saline. Extracted intestine, liver and kidneys were frozen until analysis. The Health Products and Food Branch Animal Care Committee of Health Canada approved the experimental protocol. Rats were treated in accordance with the guidelines of the Canadian Council on Animal Care.
Test diets were prepared by adding appropriate amounts of Cu (cupric carbonate) and Zn (zinc carbonate) from cornstarch premixes. Other than differences in Cu and Zn content, composition of the diets were similar to those described previously . Zn and Cu content in samples of each test diet were determined by flame atomic absorption spectrophotometry (AAS) (Perkin-Elmer 5100 PC; Perkin Elmer Cetus Instruments, Norwalk, CT) as described .
Blood samples were collected in EDTA tubes and separated into its components by centrifugation. Plasma was frozen in aliquots. White blood cells (WBCs) were carefully removed (trying to avoid contamination with erythrocytes), washed with isotonic saline and centrifuged. The procedure was repeated 3–4 times until a WBC preparation with no visible contamination with erythrocytes was obtained. Erythrocytes were washed 3 times with saline prior to freezing.
Total food consumption, body weight and Zn content in tissues of rats fed diets differing in Zn and Cu1,2
week 5 (g)
(μg/g dry weight)
(μg/g dry weight)
(μg/g dry weight)
41.27 ± 0.52a
5.70 ± 0.04a
881.0 ± 20.8a
345.1 ± 6.2a
91.99 ± 1.99a
104.82 ± 1.80a
97.12 ± 2.14a
65.09 ± 3.42b
5.57 ± 0.14a
876.9 ± 28.6a
346.3 ± 7.3a
94.08 ± 1.20a
102.42 ± 1.36a
98.94 ± 1.31a
129.18 ± 0.71c
5.77 ± 0.08a
852.8 ± 26.6a
343.4 ± 6.4a
104.40 ± 1.91b
105.95 ± 1.05a
115.28 ± 2.80b
242.22 ± 0.80d
5.78 ± 0.03a
908.6 ± 28.7a
364.9 ± 9.0b
109.33 ± 2.25b
112.97 ± 2.19b
146.04 ± 6.77c
48.48 ± 2.54e
1.07 ± 0.02b
891.2 ± 28.3a
339.0 ± 8.5a
94.69 ± 1.53a
102.07 ± 0.77a
94.93 ± 1.38a
Liver protein extracts were prepared by homogenizing in ice-cold 0.5% (v/v) Triton-X-100 buffer containing a protease inhibitor cocktail (Roche, Laval, Canada). WBCs and erythrocytes were lysed in Triton-X-100 buffer or GSH reagent (5 mmol/L KH2PO4/K2HPO4, 2 mmol/L glutathione, pH 7.0), respectively. Extracts (40 μg total protein or haemoglobin) were separated over 8–16% Tris-Glycine gradient gels (Invitrogen, Burlington, Canada) under denaturing and reducing conditions. Gels for each tissue were simultaneously electroblotted onto a single nitrocellulose membrane. The membrane was blocked for 1 h at room temperature (RT) in TBS-Tween [20 mmol/L Tris, 500 mmol/L NaCl, 0.1% Tween 20 (v/v), pH 7.5] supplemented with 5% (wt/v) nonfat dry milk (BioRad, Hercules, CA). Membranes were probed with a CCS antibody (FL-274; Santa Cruz Biotechnology, Santa Cruz, CA) at a final concentration of 0.6 mg/L (for liver and erythrocytes) or 0.2 mg/L (for WBCs) overnight at 4°C. After washing with TBS-Tween, membranes were incubated with an anti-rabbit (0.16 mg/L) HRP-conjugated secondary antibody (BioRad) in blocking solution for 2 h at RT. Antibody-bound proteins were detected by enhanced chemiluminescence and exposure to film. Membranes were stripped with stripping buffer (100 mmol/L 2-mercaptoethanol, 2% (wt/v) SDS, 62.5 mmol/L Tris-HCl, pH 6.8) and re-probed with an antibody against Actin [(I-19)-R, Santa Cruz Biotechnology] or GAPDH (MCA-1D4, Encor Biotech, Alachua, FL) at 0.5 mg/L concentration or at a 1:1000 dilution, respectively. Film was scanned and band intensity determined using Scion Image software (Scion Corporation, Frederick, MD). Band intensities were determined at exposures within the linear response range of the film.
Mineral Analyses in Tissues
Cu and Zn content in liver and kidney samples were determined by flame AAS as described . Plasma Cu concentration was measured by graphite furnace AAS using a SIMAA 6000 (Perkin-Elmer Cetus Instruments) with Zeeman background correction. To determine Zn and Cu levels in the intestinal mucosa, mucosal cells were gently scraped with a glass cover slide from a 10 cm intestinal segment starting 10 cm caudal to the pyloric sphincter. Mucosal scrapings were dried, dissolved in concentrated HNO3 and microwave digested using a CEM (Mars5) microwave (CEM Corporation, Matthews, NC). Zn and Cu in digested samples were determined by flame AAS and graphite furnace AAS, respectively.
Tissue Cu concentrations and SOD1 activity 1,2
(μg/g dry weight)
(μg/g dry weight)
(μg/g dry weight)
Liver SOD1 Activity
Erythrocyte SOD1 Activity
17.50 ± 0.87a
23.08 ± 1.07a
9.66 ± 0.25ab
27.39 ± 1.90a
53.21 ± 2.21a
16.08 ± 0.57ab
21.28 ± 1.04ab
9.21 ± 0.26ab
26.91 ± 1.15a
52.61 ± 1.97a
14.70 ± 1.07b
20.57 ± 0.85b
8.64 ± 0.51a
24.31 ± 1.84a
48.58 ± 1.45a
16.38 ± 0.65ab
21.74 ± 0.82ab
9.78 ± 0.36b
25.25 ± 1.44a
49.06 ± 1.61a
9.45 ± 0.82c
15.84 ± 0.32c
5.50 ± 0.49c
19.40 ± 1.76b
41.81 ± 1.55b
Liver and erythrocyte SOD1 activity was measured by the cytochrome c reduction assay  modified for analysis with a microplate reader. Plasma caeruloplasmin (Cp) activity was measured as described .
Effect of dietary Zn and Cu on plasma Cu concentration and Cp activity of rats
Plasma Cu Concentration1,2
No. of non-responders
No. of responders5
Test diets were prepared by adding 30, 60, 120 and 240 mg Zn/kg diet, which corresponds to normal amounts of Zn or 2, 4 or 8 times the AIN recommended amount , respectively. An additional group of rats was fed a Cu-deficient diet containing normal amounts of Zn and served as a positive control for Cu deficiency. Precise Zn and Cu content of each test diet is shown in Table 1. All test diets contained higher amounts of Zn than what would be expected from amounts added to the diet preparations. Analysis of individual dietary components revealed that casein was the major contributor to the additional Zn in the final diet preparations (data not shown).
Total food consumption of rats from each diet group was similar (Table 1). Rats fed the Zn-120 and Zn-240 diet accumulated larger (P < 0.05) amounts of Zn in the liver compared to control rats fed normal amounts of Zn (Zn-30) (Table 1). Only rats fed the largest amount of Zn (Zn-240) showed a significant (P < 0.05) increase in kidney Zn content. Zn in the intestinal mucosa of rats fed the Zn-120 or the Zn-240 diet was increased (P < 0.05). Zn content in the liver, kidney and intestinal mucosa of rats fed the Cu-deficient diet (Cu-D) was similar to that of rats fed adequate Cu (Zn-30), indicating that the Cu-deficient diet did not affect Zn accumulation in these tissues.
Rats consuming the diet containing the largest amount of Zn (Zn-240) showed a significant (P < 0.05) increase in body weight at week 4 (data not shown) and 5 (Table 1) of the study compared to rats fed normal Zn. Conversely, body weight of rats fed the Zn-60, Zn-120 or Cu-D diet did not differ from that of Zn-30 rats (Table 1). Haemoglobin (Hb) levels and other haematological parameters of rats fed elevated Zn or the Cu-D diet were similar to those of rats fed the Zn-30 diet (See additional file 1: Table 1).
Rats fed 4 times the normal level of Zn (Zn-120) showed a small decrease (P < 0.05) in liver Cu compared to rats fed normal Zn (Table 2). Surprisingly, liver Cu did not decrease further in rats fed the highest amount of Zn (Zn-240). In fact, Cu levels did not differ from those of Zn-30 rats. A similar trend was observed for kidney Cu content. Diets high in Zn did not alter Cu content in the intestinal mucosa when compared to rats fed normal Zn. However, Cu content in the intestinal mucosa was higher (P < 0.05) in Zn-240 compared to Zn-120 rats. Cu levels in the liver, kidney and intestinal mucosa of rats fed the Cu-D diet were markedly decreased (P < 0.05) compared to rats fed the control diet. Liver and erythrocyte SOD1 activity was unaffected (P > 0.05) in rats fed high Zn (Table 2). In contrast, rats fed the Cu-D diet showed a significant (P < 0.05) decrease in SOD1 activity in liver and erythrocytes.
Scatter plots of plasma Cu levels clearly showed that while some rats responded to increased dietary Zn with a reduction in plasma Cu other rats had normal levels (Figure 1A), indicating an all or none response. The number of rats that responded increased from 2 rats when fed the Zn-60 diet to 7 rats when fed the Zn-120 diet (Table 3). Consistent with liver, kidney and intestinal mucosa Cu content indicating improved Cu status in rats fed the Zn-240 diet compared to rats fed the Zn-120 diet, only 3 rats fed the Zn-240 diet were characterised as responders. The response mean for plasma Cu was also higher in Zn-240 compared to Zn-120 rats (Figure 1A). Plasma Cu of Cu-D rats was markedly decreased, consistent with data from a previous study from our laboratory . As expected, given that most plasma Cu is associated with Cp, Cp activity paralleled very closely plasma Cu levels and showed a similar all or none response behaviour (Figure 1B, Table 3). A strong positive correlation (r = 0.984) was found between plasma Cu and Cp activity (data not shown).
Comparison of tissue CCS expression between Zn-30 rats and responders and non-responders for plasma Cu1,2
1.00 ± 0.14a
(n = 12)
1.00 ± 0.18a
(n = 12)
1.00 ± 0.20a
(n = 7)
1.18 ± 0.11a
(n = 24)
1.44 ± 0.16ab
(n = 24)
0.95 ± 0.11a
(n = 17)
1.97 ± 0.12b
(n = 12)
1.86 ± 0.20b
(n = 12)
2.02 ± 0.54b
(n = 4)
Correlation between CCS content in tissues and liver and plasma Cu concentration, Cp activity and liver and erythrocyte SOD1 activity1,2
Diet Groups3, n = 60
Diet Groups4, n = 48
This is the first study to demonstrate that CCS protein expression responds to mild Cu deficiency induced by moderately high dietary Zn, underscoring the potential usefulness of CCS as a biomarker in a clinical setting. In contrast to rats and mice used in previous studies [19, 21, 22], rats used in this study had normal haematology and did not show any indications of the development of anaemia, indicating that these rats were not overtly Cu deficient. Further, rats did not show impaired growth, a phenotype associated with severe Cu deficiency in growing rats .
Erythrocyte CCS expression was determined to be the most sensitive index of reduced Cu nutriture and was able to detect a decrease in Cu status in rats fed only twice the AIN recommended amount of Zn . This sensitivity may also partly account for the absence of a significant difference in erythrocyte CCS expression between responders and non-responders for plasma Cu, as CCS may have increased in some rats fed high Zn but characterise as non-responders. Notably, erythrocyte CCS expression in non-responders was higher than in Zn-30 rats and this difference was approaching statistical significance (P = 0.09). Liver CCS also responded to elevated dietary Zn and was increased in rats fed 4 times the recommended amount. These are important findings, as these same rats did not show a significant decrease in SOD1 activity, the biomarker of reduced Cu status used to set the ULs for Zn.
Rats fed elevated Zn showed an all or none response for decreased plasma Cu and Cp activity, indicating that these parameters are not ideal for diagnosing small reductions in Cu status and providing an accurate assessment of precise Cu nutriture. These data are consistent with a previous study showing a similar all or none response for Cp activity in rats fed elevated levels of Zn . This response likely reflects the presence of strong homeostatic mechanisms that maintain plasma Cu levels in the normal range until liver stores have been appreciably depleted.
Although a gold standard for assessing reductions in Cu status is lacking, decreased liver Cu content is regarded as one of the most accurate and sensitive measures in experimental animals, while plasma Cu and Cp activity are the most common indicators used in clinical situations. The strong inverse correlation of liver CCS expression with these markers indicates that increased CCS expression was specific for reduced Cu status and is a good predictor of changes in common measures of Cu deficiency. Erythrocyte CCS showed a weaker association with these indicators that may be explained, in part, by the slow turnover of erythrocytes, which may not accurately reflect the current Cu status of the rats. This is in contrast to plasma and liver Cu levels and Cp activity that likely respond more rapidly to changes in Cu availability.
During our experiments we discovered that CCS protein in WBCs is more susceptible to degradation than CCS in erythrocytes, requiring that WBCs be isolated quickly from blood samples. Samples showing degradation of CCS were excluded from our analyses. Of the 7 rats per diet group analysed, we noticed that the majority of rats fed high Zn were characterised as non-responders for decreased plasma Cu and Cp activity. This over sampling of rats showing normal plasma Cu and Cp activity may account for the absence of a significant increase in WBC CCS in rats fed elevated Zn. Nonetheless, WBC CCS expression was increased in rats fed the Cu-deficient diet and was highly correlated with conventional measures of Cu status. Further, rats characterised as responders for plasma Cu (which represents rats with poorer Cu status) had higher WBC CCS levels than non-responders or Zn-30 rats, indicating that WBC CCS responds to Cu deficiency induced by excess zinc. Because of the slow turnover of erythrocytes, WBC CCS may have value as an indicator of early reductions in Cu status. Interestingly, we found that the basal expression level of CCS in WBCs is much higher than in other tissues such as liver, heart and erythrocytes in rats (data not shown).
A major finding of this paper is that rats fed 8 times the recommended amount of Zn (Zn-240) showed overall better Cu status than rats fed 4 times the recommended amount (Zn-120). This was consistently observed with several biomarkers. Remarkably, Cu status indicators of most rats fed the Zn-240 diet were indistinguishable from rats fed a diet normal in Zn. Importantly, liver CCS was significantly lower in Zn-240 compared to Zn-120 rats, further demonstrating the exquisite sensitivity of CCS to changes in Cu status. At this point, we cannot offer a definite explanation as to why other studies from our laboratory [9, 34] failed to detect this biphasic response, other than to speculate that differences in the bioavailability of the Zn source, other dietary components or duration of the studies may account for this discrepancy.
Presently, the mechanism by which Zn interferes with Cu absorption is unknown, although it is believed to occur at the site of the intestinal enterocyte. It was thought that increased metallothionein (MT) levels sequestered Cu in the enterocyte leading to Cu deficiency [35, 36]. However, MT-null mice fed elevated Zn become Cu deficient indicating that MT induction is not the primary cause of the Cu deficiency . Results presented here are consistent with these data, as rats fed the Zn-60 and Zn-120 diet showed reduced Cu status in the absence of increased duodenal MT-1 transcript. Because MT can bind Cu, however, it would be interesting to determine whether higher MT-1 expression in Zn-240 rats played any role in increasing Cu in the intestinal mucosa and improving Cu status of these rats compared to Zn-120 rats.
Experiments with Caco-2 cells have indicated that elevated levels of Zn affect Cu transport and reduce Cu efflux at the basolateral side , suggesting that Zn may block absorption of Cu by affecting the activity of a Cu transporter. Thus, improved Cu status of Zn-240 compared to Zn-120 rats may reflect a secondary effect of the higher Zn diet on the activity of a Cu transporter. It is known that distinct pools of Zn exist within cells and changes in expression of Zn-trafficking proteins can alter the intracellular distribution of Zn . For example, increased expression of ZnT-2 likely promotes the accumulation of Zn within vesicles, decreasing cytoplasmic Zn levels . In addition, increased MT levels result in more Zn bound to MT. Given that transcripts of several Zn-trafficking proteins were increased in the duodenum of rats fed the Zn-240 but not the Zn-120 diet, it is possible that increased expression of one or more of these Zn-trafficking proteins altered the distribution of Zn within absorptive enterocytes of Zn-240 rats in a manner that alleviated the block in activity of a Cu transporter.
Lastly, we report an interesting observation that rats fed the highest level of Zn had increased body weight. Although it is well recognized that Zn deficiency can result in impaired growth , it is not established that consuming larger quantities of Zn, above recommend amounts, can enhance growth. Given that lower doses of Zn above the AIN recommended amount clearly depressed Cu status of rats, the benefit of consuming this higher level of Zn is presently unclear.
In this study we report two major discoveries. Firstly, we show that CCS is a sensitive biomarker of Zn-induced mild Cu deficiency in rats. Given this finding, further studies evaluating CCS as a biomarker in humans are necessary, as CCS may prove to be a better measure of reduced Cu status than conventional indicators and impact studies aimed at setting more accurate Dietary Reference Intakes for Zn and Cu. Secondly, we demonstrate a dose-dependent biphasic response for the reduction of Cu status by moderately high intakes of Zn. Although it is not known whether humans respond to excess Zn in a similar manner to rats, this finding offers a caution when interpreting data from studies reporting no reduction in Cu status that have used a single dose of supplemental Zn and emphasizes the importance of using a dose-response approach.
We thank the Animal Resource Division of Health Canada for assistance in care of the rats. We would also like to acknowledge Stephen Hayward for assistance with the statistical analyses. Bingtuan Wang is a National Institute of Nutrition (NIN) Post-doctoral Fellow. This study was funded by the Bureau of Nutritional Sciences, Health Canada. This is publication no. 607 of the Bureau of Nutritional Sciences.
- Institute of Medicine: Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC. 2001Google Scholar
- Schumann K, Classen HG, Dieter HH, Konig J, Multhaup G, Rukgauer M, Summer KH, Bernhardt J, Biesalski HK: Hohenheim consensus workshop: copper. Eur J Clin Nutr. 2002, 56: 469-83. 10.1038/sj.ejcn.1601315.View ArticlePubMedGoogle Scholar
- McCall KA, Huang C, Fierke CA: Function and mechanism of zinc metalloenzymes. J Nutr. 2000, 130: 1437S-46S.PubMedGoogle Scholar
- Botash AS, Nasca J, Dubowy R, Weinberger HL, Oliphant M: Zinc-induced copper deficiency in an infant. Am J Dis Child. 1992, 146: 709-11.PubMedGoogle Scholar
- Porea TJ, Belmont JW, Mahoney DH: Zinc-induced anemia and neutropenia in an adolescent. J Pediatr. 2000, 136: 688-90. 10.1067/mpd.2000.103355.View ArticlePubMedGoogle Scholar
- Broun ER, Greist A, Tricot G, Hoffman R: Excessive zinc ingestion. A reversible cause of sideroblastic anemia and bone marrow depression. JAMA. 1990, 264: 1441-3. 10.1001/jama.264.11.1441.View ArticlePubMedGoogle Scholar
- Hein MS: Copper deficiency anemia and nephrosis in zinc-toxicity: a case report. S D J Med. 2003, 56: 143-7.PubMedGoogle Scholar
- Willis MS, Monaghan SA, Miller ML, McKenna RW, Perkins WD, Levinson BS, Bhushan V, Kroft SH: Zinc-induced copper deficiency: a report of three cases initially recognized on bone marrow examination. Am J Clin Pathol. 2005, 123: 125-31. 10.1309/V6GV-YW2Q-TYD5-C5PJ.View ArticlePubMedGoogle Scholar
- L'Abbe MR, Fischer PW: The effects of dietary zinc on the activity of copper-requiring metalloenzymes in the rat. J Nutr. 1984, 114: 823-8.PubMedGoogle Scholar
- L'Abbe MR, Fischer PW: The effects of high dietary zinc and copper deficiency on the activity of copper-requiring metalloenzymes in the growing rat. J Nutr. 1984, 114: 813-22.PubMedGoogle Scholar
- Fischer PW, Giroux A, L'Abbe MR: Effect of zinc supplementation on copper status in adult man. Am J Clin Nutr. 1984, 40: 743-6.PubMedGoogle Scholar
- Yadrick MK, Kenney MA, Winterfeldt EA: Iron, copper, and zinc status: response to supplementation with zinc or zinc and iron in adult females. Am J Clin Nutr. 1989, 49: 145-50.PubMedGoogle Scholar
- Williams DM: Copper deficiency in humans. Semin Hematol. 1983, 20: 118-28.PubMedGoogle Scholar
- Milne DB: Assessment of copper nutritional status. Clin Chem. 1994, 40: 1479-84.PubMedGoogle Scholar
- Milne DB: Copper intake and assessment of copper status. Am J Clin Nutr. 1998, 67: 1041S-1045S.PubMedGoogle Scholar
- Arsenault JE, Brown KH: Zinc intake of US preschool children exceeds new dietary reference intakes. Am J Clin Nutr. 2003, 78: 1011-7.PubMedGoogle Scholar
- Bialostosky K, Wright JD, Kennedy-Stephenson J, McDowell MA, Johnson CL: Dietary intakes of macronutrients, micronutrients, and other dietary constituents: United States, 1988–94. Vital Health Stat 11. 2002, 245: 1-168.PubMedGoogle Scholar
- Hunt CD, Meacham SL: Aluminum, boron, calcium, copper, iron, magnesium, manganese, molybdenum, phosphorus, potassium, sodium, and zinc: concentrations in common western foods and estimated daily intakes by infants; toddlers; and male and female adolescents, adults, and seniors in the United States. J Am Diet Assoc. 2001, 101: 1058-60. 10.1016/S0002-8223(01)00260-7.View ArticlePubMedGoogle Scholar
- Bertinato J, Iskandar M, L'Abbe MR: Copper deficiency induces the upregulation of the copper chaperone for Cu/Zn superoxide dismutase in weanling male rats. J Nutr. 2003, 133: 28-31.PubMedGoogle Scholar
- Bertinato J, L'Abbe MR: Copper modulates the degradation of copper chaperone for Cu,Zn superoxide dismutase by the 26 S proteosome. J Biol Chem. 2003, 278: 35071-8. 10.1074/jbc.M302242200.View ArticlePubMedGoogle Scholar
- West EC, Prohaska JR: Cu,Zn-superoxide dismutase is lower and copper chaperone CCS is higher in erythrocytes of copper-deficient rats and mice. Exp Biol Med (Maywood). 2004, 229: 756-64.Google Scholar
- Prohaska JR, Broderius M, Brokate B: Metallochaperone for Cu,Zn-superoxide dismutase (CCS) protein but not mRNA is higher in organs from copper-deficient mice and rats. Arch Biochem Biophys. 2003, 417: 227-34. 10.1016/S0003-9861(03)00364-3.View ArticlePubMedGoogle Scholar
- Fischer PW, L'Abbe MR, Giroux A: Effects of smoking, drinking, exercise and estrogen use on indices of copper status in healthy adults. Nutr Res. 1990, 10: 1081-90.View ArticleGoogle Scholar
- Lukaski HC, Hoverson BS, Gallagher SK, Bolonchuk WW: Physical training and copper, iron, and zinc status of swimmers. Am J Clin Nutr. 1990, 51: 1093-9.PubMedGoogle Scholar
- Del Villano DC, Miller SI, Schacter LP, Tischfield JA: Elevated superoxide dismutase in black alcoholics. Science. 1980, 207: 991-3.View ArticlePubMedGoogle Scholar
- Danks DM: Copper deficiency in humans. Annu Rev Nutr. 1988, 8: 235-57. 10.1146/annurev.nu.08.070188.001315.View ArticlePubMedGoogle Scholar
- Wildman RE, Hopkins R, Failla ML, Medeiros DM: Marginal copper-restricted diets produce altered cardiac ultrastructure in the rat. Proc Soc Exp Biol Med. 1995, 210: 43-9.View ArticlePubMedGoogle Scholar
- Li Y, Wang L, Schuschke DA, Zhou Z, Saari JT, Kang YJ: Marginal dietary copper restriction induces cardiomyopathy in rats. J Nutr. 2005, 135: 2130-6.PubMedGoogle Scholar
- Reeves PG, Nielsen FH, Fahey GC: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993, 123: 1939-51.PubMedGoogle Scholar
- Cockell KA, Fischer PW, Belonje B: Elemental composition of anatomically distinct regions of rat liver. Biol Trace Elem Res. 1999, 70: 251-63.View ArticlePubMedGoogle Scholar
- L'Abbe MR, Fischer PW: Automated assay of superoxide dismutase in blood. Methods Enzymol. 1990, 186: 232-7.View ArticlePubMedGoogle Scholar
- Schosinsky KH, Lehmann HP, Beeler MF: Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin Chem. 1974, 20: 1556-63.PubMedGoogle Scholar
- Report of the American Institute of Nutrition ad hoc Committee on Standards for Nutritional Studies. J Nutr. 1977, 107: 1340-8.
- Fischer PW, Giroux A, L'Abbe MR: The effect of dietary zinc on intestinal copper absorption. Am J Clin Nutr. 1981, 34: 1670-5.PubMedGoogle Scholar
- Hall AC, Young BW, Bremner I: Intestinal metallothionein and the mutual antagonism between copper and zinc in the rat. J Inorg Biochem. 1979, 11: 57-66. 10.1016/S0162-0134(00)80054-9.View ArticlePubMedGoogle Scholar
- Fischer PW, Giroux A, L'Abbe MR: Effects of zinc on mucosal copper binding and on the kinetics of copper absorption. J Nutr. 1983, 113: 462-9.PubMedGoogle Scholar
- Reeves PG: Copper metabolism in metallothionein-null mice fed a high zinc diet. J of Nutr Biochem. 1998, 9: 598-601. 10.1016/S0955-2863(98)00055-2.View ArticleGoogle Scholar
- Reeves PG, Briske-Anderson M, Johnson L: Physiologic concentrations of zinc affect the kinetics of copper uptake and transport in the human intestinal cell model, Caco-2. J Nutr. 1998, 128: 1794-801.PubMedGoogle Scholar
- Liuzzi JP, Cousins RJ: Mammalian zinc transporters. Annu Rev Nutr. 2004, 24: 151-72. 10.1146/annurev.nutr.24.012003.132402.View ArticlePubMedGoogle Scholar
- Palmiter RD, Cole TB, Findley SD: ZnT-2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration. EMBO J. 1996, 15: 1784-91.PubMedPubMed CentralGoogle Scholar
- Brown KH, Peerson JM, Allen LH: Effect of zinc supplementation on children's growth: a meta-analysis of intervention trials. Bibl Nutr Dieta. 1998, 54: 76-83.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.